Loss of chromosome 13q is associated with malignant potential in pulmonary carcinoids

Cancer Genomics and Proteomics

Volumn 3, Issue 1, 2006, Pages 39-45

  Inamura, Kentaro ^a   Furuta, Reiko ^a   Satoh, Yukitoshi ^a,b   Shirakawa, Takashi ^a,e   Okumura, Sakae ^b   Nakagawa, Ken ^b   Fujiwara, Mutsunori ^c   Tsuchiya, Eiju ^d   Ishikawa, Yuichi ^a  

^a CANCER INSTITUTE   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

^c JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^d KANAGAWA CANCER CENTER   (Japan)

^e FUJIREBIO INC   (Japan)

Author keywords

Carcinoid; Chromosome 13q; Comparative genomic hybridization; Lung; Retinoblastoma protein

Indexed keywords

DNA; KI 67 ANTIGEN; RETINOBLASTOMA PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CARCINOID; CELL DEATH; CHROMOSOME 13Q; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; ENDOSCOPIC POLYPECTOMY; FEMALE; GENETIC MARKER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARYOTYPING; LUNG CARCINOID; LUNG LOBECTOMY; LYMPH NODE METASTASIS; MALE; MITOSIS; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 33144470966     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Travis WD, Colby TV, Corrin B, Shimosato Y and Brambilla E: International Histological Classification of Tumours: Histological Typing of Lung and Pleural Tumours, 3rd ed. Berlin: Springer, 1999.
2. Cardillo G, Sera F, Di Martino M, Graziano P, Giunti R, Carbone L, Facciolo F and Martelli M: Bronchial carcinoid tumors: nodal status and long-term survival after resection. Ann Thorac Surg 77: 1781-1785, 2004.
3. Travis WD, Rush W, Flieder DB, Falk R, Fleming MV, Gal AA and Koss MN: Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 22: 934-944, 1998.
4. Granberg D, Wilander E, Oberg K and Skogseid B: Prognostic markers in patients with typical bronchial carcinoid tumors. J Clin Endocrinol Metab 85: 3425-3430, 2000.
5. Onuki N, Wistuba II, Travis WD, Virmani AK, Yashima K, Brambilla E, Hasleton P and Gazdar AF: Genetic changes in the spectrum of neuroendocrine lung tumors. Cancer 85: 600-607, 1999.
6. Walch AK, Zitzelsberger HF, Aubele MM, Mattis AE, Bauchinger M, Candidus S, Prauer HW, Werner M and Hofler H: Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization. Am J Pathol 153: 1089-1098, 1998.
7. Petzmann S, Ullmann R, Halbwedl I and Popper HH: Analysis of chromosome-11 aberrations in pulmonary and gastrointestinal carcinoids: an array comparative genomic hybridization-based study. Virchows Arch 445: 151-159, 2004.
8. Ullmann R, Petzmann S, Klemen H, Fraire AE, Hasleton P and Popper HH: The position of pulmonary carcinoids within the spectrum of neuroendocrine tumors of the lung and other tissues. Genes Chromosomes Cancer 34: 78-85, 2002.
9. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U and Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710-1715, 1984.
10. Mitelman F: Guidelines for Cancer Cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature. Basel: Karger, 1995.
11. Zhao J, de Krijger RR, Meier D, Speel EJ, Saremaslani P, Muletta-Feurer S, Matter C, Roth J, Heitz PU and Komminoth P: Genomic alterations in well-differentiated gastrointestinal and bronchial neuroendocrine tumors (carcinoids): marked differences indicating diversity in molecular pathogenesis. Am J Pathol 157: 1431-1438, 2000.
12. Travis WD, Gal AA, Colby TV, Klimstra DS, Falk R and Koss MN: Reproducibility of neuroendocrine lung tumor classification. Hum Pathol 29: 272-279, 1998.
13. Benedict WF, Xu HJ, Hu SX and Takahashi R: Role of the retinoblastoma gene in the initiation and progression of human cancer. J Clin Invest 85: 988-993, 1990.
14. Kobayashi Y, Tokuchi Y, Hashimoto T, Hayashi M, Nishimura H, Ishikawa Y, Nakagawa K, Sato Y, Takahashi A and Tsuchiya E: Molecular markers for reinforcement of histological subclassification of neuroendocrine lung tumors. Cancer Sci 95: 334-341, 2004.
15. Gouyer V, Gazzeri S, Brambilla E, Bolon I, Moro D, Perron P, Benabid AL and Brambilla C: Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuro-endocrine lung carcinomas. Int J Cancer 58: 818-824, 1994.
16. Cagle PT, el-Naggar AK, Xu HJ, Hu SX and Benedict WF: Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implications. Am J Pathol 150: 393-400, 1997.
17. Lai SL, Brauch H, Knutsen T, Johnson BE, Nau MM, Mitsudomi T, Tsai CM, Whang-Peng J, Zbar B, Kaye FJ and Gazdar AF: Molecular genetic characterization of neuroendocrine lung cancer cell lines. Anticancer Res 15: 225-232, 1995.
18. Borg A, Zhang QX, Alm P, Olsson H and Sellberg G: The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression. Cancer Res 52: 2991-2994, 1992.
19. Cooney KA, Wetzel JC, Merajver SD, Macoska JA, Singleton TP and Wojno KJ: Distinct regions of allelic loss on 13q in prostate cancer. Cancer Res 56: 1142-1145, 1996.
20. Dodson MK, Cliby WA, Xu HJ, DeLacey KA, Hu SX, Keeney GL, Li J, Podratz KC, Jenkins RB and Benedict WF: Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus. Cancer Res 54: 610-613, 1994.
21. Kim TM, Benedict WF, Xu HJ, Hu SX, Gosewehr J, Velicescu M, Yin E, Zheng J, D'Ablaing G and Dubeau L: Loss of heterozygosity on chromosome 13 is common only in the biologically more aggressive subtypes of ovarian epithelial tumors and is associated with normal retinoblastoma gene expression. Cancer Res 54: 605-609, 1994.
22. Yoo GH, Xu HJ, Brennan JA, Westra W, Hruban RH, Koch W, Benedict WF and Sidransky D: Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res 54: 4603-4606, 1994.